Skip Navigation LinksHome > January 2014 - Volume 18 - Issue 1 > Cervical Cancer Rates After the Transition From Annual Pap t...
Journal of Lower Genital Tract Disease:
doi: 10.1097/LGT.0b013e31829325c3
Original Articles

Cervical Cancer Rates After the Transition From Annual Pap to 3-Year HPV and Pap

Dinkelspiel, Helen MD1; Fetterman, Barbara SCT (ASCP)2; Poitras, Nancy PMP2; Kinney, Walter MD3; Cox, J. Thomas MD4; Lorey, Thomas MD2; Castle, Philip E. PhD, MPH5

Collapse Box


Objective: Kaiser Permanente Northern California (KPNC) introduced 3-year Pap and human papillomavirus DNA cotesting for cervical cancer screening in women 30 years or older in 2003 to 2004. Patient and provider willingness to extend screening intervals and the impact on annual cervical cancer incidence after interval extension are evaluated.

Materials and Methods: Age-adjusted cervical cancer rates and screening intervals were calculated from KPNC Regional Laboratory databases and Northern California Cancer Registry from 2000 to 2009.

Results: The median screening interval between negative cotests was 36 months compared to the 16 months after a negative Pap test alone before the implementation of cotesting. The age-adjusted invasive cancer rate was 6.5 per 100,000 women in 2000 and 6.3 in 2009; there was no difference in the rates of cervical cancer in women 30 years or older from 2000 to 2009 (ptrend = .7).

Conclusions: Patients and providers were compliant with the extension of screening intervals with cotesting. Cervical cancer rates remained constant during the 10-year study period despite extending screening intervals after a negative cotest.

Copyright © 2014 by the American Society for Colposcopy and Cervical Pathology


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.